Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-008320
Filing Date
2025-05-23
Accepted
2025-05-23 16:47:21
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-69669.html 4  
1 PRIMARY DOCUMENT marketforms-69669.xml 4 3578
  Complete submission text file 0001214659-25-008320.txt   5249
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address
Hernday Natasha (Reporting) CIK: 0001780547 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39801 | Film No.: 25983108